Next week, over 40 African heads of state will convene in Washington, D.C. for the first-ever U.S.-Africa Leaders Summit. One important issue that requires attention at the meeting is strengthening the response to infectious diseases including HIV/AIDS, malaria, Ebola and tuberculosis (TB) that threaten lives, economies and national security.

You are invited to attend the following virtual scientific lectures:

Several community groups express concerns regarding the STREAM stage II trial design for bedaquiline approval.

Foreward

HIV and tuberculosis advocates say failure by donors and governments to invest more in these diseases may thwart efforts to end both epidemics resulting in thousands of preventable deaths.

Researchers have uncovered a way the malaria parasite becomes resistant to an investigational drug. The discovery, at Washington University School of Medicine in St. Louis, also is relevant for other infectious diseases including bacterial infections and tuberculosis.

“We must focus upon individual human beings rather than on individual diseases of TB and HIV. A person centric approach is bound to work together than a disease centric approach,” said Mark Dybul, Executive Director, Global Fund to fight AIDS, Tuberculosis and Malaria at a high level WHO consultation, held in conjunction with 20th International AIDS Conference (AIDS 2014), to discuss policies to catalyze the response for elimination of TB deaths among people living with HIV (PLHIV).

MELBOURNE, AUSTRALIA – “Why do we still have 320,000 deaths from TB in people living with HIV each year?”

Decentralisation of drug-resistant tuberculosis (DR-TB) management and use of the Xpert MTB/RIF test improves the time from clinic presentation to treatment from 50 days to 7 days in a population with a high burden of HIV and TB co-infection, according to a study from Khayelitsha, South Africa, presented at the 20th International AIDS Conference (AIDS 2014) on Monday.

New research aims to estimate the benefits of different ways to carry out screening both patients with tuberculosis (TB) for diabetes and the other way around in parts of the world where both diseases are common.